Your session is about to expire
← Back to Search
Cold Plasma
Cold Plasma for Hair Loss
N/A
Waitlist Available
Research Sponsored by Dr. Peter C. Friedman
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months and 6 months
Awards & highlights
Study Summary
This trial found that a self-applied cold plasma activated medium may be an effective treatment for androgenetic alopecia.
Eligible Conditions
- Male Pattern Baldness
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months and 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months and 6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Presence of detectable hair growth
Secondary outcome measures
Adverse effects related to the treatment
Trial Design
1Treatment groups
Experimental Treatment
Group I: Cold-atmospeheric pressure plasma activated solutionExperimental Treatment1 Intervention
Treatment arm subjects receive the trial intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cold-atmospeheric pressure plasma activated aqueous-alcohol solution treatment
2020
N/A
~20
Find a Location
Who is running the clinical trial?
Dr. Peter C. FriedmanLead Sponsor
1 Previous Clinical Trials
15 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have started or stopped any hair loss treatments within the last 6 months before the study.You are able to follow the treatment plan consistently.You have any type of scalp inflammation.You have mild to moderate hair loss caused by genetics (androgenetic alopecia).
Research Study Groups:
This trial has the following groups:- Group 1: Cold-atmospeheric pressure plasma activated solution
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Male Pattern Baldness Patient Testimony for trial: Trial Name: NCT04379752 — N/A
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there vacancies available for individuals to partake in this clinical trial?
"According to information available on clinicaltrials.gov, this medical experiment is recruiting participants and has been since July 1st 2020 (most recently reviewed April 10th 2022)."
Answered by AI
What is the participant tally for this investigation?
"Affirmative. As evidenced by the information on clinicaltrials.gov, this medical trial is still recruiting participants - it was first posted in July 1st 2020 and its most recent update occurred April 10th 2022. A total of 40 individuals are needed at one location for participation purposes."
Answered by AI
Who else is applying?
How old are they?
18 - 65
What site did they apply to?
The Skin Center Dermatology Group
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
What state do they live in?
Pennsylvania
New York
How many prior treatments have patients received?
0
1
3+
Why did patients apply to this trial?
I’m trying to discover ways to treat half a lifetime worth of male pattern baldness.
PatientReceived 1 prior treatment
I've been experiencing hair thinning and hair loss and I would like to act before it gets too late.
PatientReceived 1 prior treatment
I've yet to try minoxidil and spironolactone due to low blood pressure. I have had one PRP treatment previously with limited success. Would love to try cold plasma to see if it can help.
PatientReceived 1 prior treatment
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger